Combination therapy with ruxolitinib and pegylated interferon alfa-2a in newly diagnosed patients with polycythemia vera
Key PointsTreatment with ruxolitinib and interferon alfa-2a is well tolerated with anemia as the main cause for dose reduction.Treatment with ruxolitinib a